Touraine, CĂ©lia
Cuer, Benjamin
Conroy, Thierry
Juzyna, Beata
Gourgou, Sophie
Mollevi, Caroline
Funding for this research was provided by:
Ligue nationale contre le cancer ("Projet de Recherche en Epidémiologie Ligue" 2019)
SIRIC Montpellier Cancer (INCa_Inserm_DGOS_12553, INCa_Inserm_DGOS_12553, INCa_Inserm_DGOS_12553)
Article History
Received: 22 June 2022
Accepted: 19 January 2023
First Online: 10 February 2023
Declarations
:
: In this study, we take data from the PRODIGE 4/ACCORD 11 clinical trial (ClinicalTrials.gov Identifier: NCT00112658). All participants of the PRODIGE 4/ACCORD 11 trial provided written informed consent. We obtained permission for the data base access from the sponsor UNICANCER R&D.
: Not applicable.
: The authors declare that they have no competing interests.